摘要
目的 为促进胃癌患者机体各项证候改善，调节机体肿瘤标志物水平，提高生存质量，对中医健脾养胃法的应用效果作进行探讨。方法 以2022年1月-2023年12月为研究时间，择取期间内本院法医临床科室收集的胃癌患者中的60例作为研究对象，依照不同治疗方法予以分组，常规化疗治疗的对照组（30例）、联合中医健脾养胃法治疗的观察组（30例），根据研究数据对比临床治疗效果（从患者证候积分、肿瘤标志物水平、生存质量评分展开数据研究）。结果 统计研究表明，观察组患者治疗后观察组主症积分、次症积分低于对照组，生存质量评分高于对照组，组间数据差异明显，P＜0.05，存在对比意义。癌胚抗原、血清糖链抗原125、血清糖链抗原50三项肿瘤标志物水平两组组间比较，差异无统计学意义，P＞0.05。结论 分析表明，中医健脾养胃法对胃癌患者机体的各项证候有显著改善作用，有效调节患者机体中肿瘤标志物水平，提高其生存质量，治疗效果显著，应用价值良好，建议推广应用。
关键词： 中医治疗；健脾养胃法；胃癌；治疗效果
Abstract
Objective In order to promote the improvement of various syndrome in gastric cancer patients, regulate the level of tumor markers and improve the quality of life, to discuss the application effect of traditional Chinese medicine spleen and stomach. Methods From January 2022 to December 2023,60 cases of gastric cancer patients collected by our forensic clinical department during the selection, grouped according to different treatment methods, the control group of conventional chemotherapy (30 cases), the observation group of TCM spleen nourishing gastric treatment (30 cases), compared the clinical treatment effect according to the study data (from the patient syndrome, tumor marker level and survival quality score data study). Results The statistical study showed that the score of the observation group in the observation group were lower than that of the control group, and the quality of survival score was higher than that of the control group. The data between the groups were obvious, P <0.05, which had comparative significance. The levels of carcinoembryonic antigen, serum glucose chain antigen 125 and serum glucose chain antigen 50 showed no significant difference, P> 0.05. Conclusion The analysis shows that the traditional Chinese medicine method of invigorating spleen and nourishing stomach can significantly improve the syndrome of gastric cancer patients, effectively regulate the level of tumor markers in patients' body, improve their quality of life, with significant therapeutic effect and good application value. It is suggested to promote and apply it.
Key words： Traditional Chinese medicine treatment; spleen and stomach nourishing method; gastric cancer; treatment effect
参考文献 References
[1] 李娜,张丙航,凌湘力,等. 全国名中医凌湘力教授运用"和衡"法辨治胃癌的经验[J]. 当代医药论丛,2023, 21(7):169-171.
[2] 朱广辉,李杰,田启航,等. 中医“胃气”理论指导下多角度治疗胃癌[J]. 辽宁中医药大学学报,2020,22(8):36-39.
[3] 张春盛,丘振文. 健脾养胃膏对胃癌术后患者免疫状态的影响观察[J]. 北方药学,2020,17(1):16-17.
[4] 曹爽,吴亚,朱颉,等.健脾养胃方联合化疗对胃癌患者T细胞亚群、凝血标志物的影响[J]. 中国现代医学杂志, 2023,33(19):24-29.
[5] 谢晓东,强永虎,刘沈林,等. 健脾养胃方联合新辅助化疗对胃癌患者临床疗效的影响及机制研究[J]. 南京中医药大学学报,2021,37(2):198-204.
[6] 杜丽,张文静. 健脾养胃补血汤治疗胃癌化疗后不良反应的临床有效性及安全性分析[J]. 光明中医,2021, 36(15):2500-2502.
[7] 孙艳,涂建龙,李子木,等. 健脾养胃膏联合甲地孕酮治疗中晚期胃癌伴恶病质患者的临床疗效观察[J]. 中国中医药科技,2022,29(3):412-414.
[8] 徐硕,向春婕,吴娟,等. 健脾养胃法对胃癌化疗患者舌苔真菌的影响[J]. 中华中医药杂志,2021,36(1):584-587.
[9] 鲁晓娜,黄雯洁,舒鹏. 健脾养胃法治疗胃癌作用及机制研究进展[J].环球中医药,2020,13(11):1991-1995.
[10] 吴娟,滕钰浩,董伟,等.健脾养胃方加减对胃癌化疗患者肠道菌群的影响[J]. 中医杂志,2019,60(6):497-502.